These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 811354)

  • 1. Smooth muscle-associated antigen in experimental cutaneous squamous cell carcinoma, keratoacanthoma, and papilloma.
    Toh BH; Muller HK
    Cancer Res; 1975 Dec; 35(12):3741-5. PubMed ID: 811354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal antigens in experimental keratoacanthoma and squamous cell carcinoma.
    Muller HK; Flannery GR
    Cancer Res; 1973 Sep; 33(9):2181-6. PubMed ID: 4579775
    [No Abstract]   [Full Text] [Related]  

  • 3. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
    Klein-Szanto AJ; Barr RJ; Reiners JJ; Mamrack MD
    Arch Pathol Lab Med; 1984 Nov; 108(11):888-90. PubMed ID: 6385922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-immunological regression of dimethylbenz(A) anthracene-induced experimental keratoacanthomas in the rabbit.
    Ramselaar CG; van der Meer JB
    Dermatologica; 1979; 158(2):142-51. PubMed ID: 104893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas.
    Klein-Szanto AJ; Nelson KG; Shah Y; Slaga TJ
    J Natl Cancer Inst; 1983 Jan; 70(1):161-8. PubMed ID: 6185712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model.
    Corominas M; Leon J; Kamino H; Cruz-Alvarez M; Novick SC; Pellicer A
    Oncogene; 1991 Apr; 6(4):645-51. PubMed ID: 1840681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
    Yokota K; Gill TJ; Shinozuka H
    Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of neoplastic progression and tumor behavior in skin carcinogenesis by different methods: an experimental study.
    Stenbäck F
    Oncology; 1980; 37(3):163-8. PubMed ID: 6767211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effect of different carcinogens on the skin of rats].
    Zabezhinskiĭ MA; Pliss GB; Okulov VB; Petrov AS
    Eksp Onkol; 1984; 6(5):24-7. PubMed ID: 6439546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin carcinogenesis as a model system: observations on species, strain and tissue sensitivity to 7,12-dimethylbenz(a)anthracene with or without promotion from croton oil.
    Stenbäck F
    Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):89-97. PubMed ID: 6767338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Another contribution to the problem of keratoacanthomas].
    Maggiora A
    Dermatologica; 1968; 137(4):2639. PubMed ID: 5685903
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea.
    Katiyar SK; Agarwal R; Mukhtar H
    Cancer Res; 1993 Nov; 53(22):5409-12. PubMed ID: 8221679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin.
    Ariano MC; Wiley EL; Ariano L; Coon JS; Tetzlaff L
    J Dermatol Surg Oncol; 1985 Nov; 11(11):1076-83. PubMed ID: 3902925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic changes in mouse epidermis at various stages of neoplastic transformation.
    Carruthers C; Bhattacharaya M
    Gan; 1972 Jun; 63(3):299-305. PubMed ID: 4627370
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas.
    Williams IR; Ort RJ; Daley D; Manning L; Karaoli T; Barnhill RL; Kupper TS
    J Immunol; 1996 May; 156(9):3382-8. PubMed ID: 8617964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.